摘要
1. Introduction Pulmonary diseases present one of the most severe threats to human society. Since late 2019, the coronavirus disease 2019(COVID-19) pandemic has significantly impacted the lifestyle, culture, and politics of almost everyone in the world. COVID-19 causes severe pulmonary dysfunction, which is a major cause of mortality for those affected [1].
基金
support from the National Institutes of Health (U18TR003778, R01GM141055, R01GM132603, and R01GM135486)
National Science Foundation (ECCS-1807601) to Tony Jun Huang
Roy J. Carver faculty start-up fund
University of Iowa to Yuliang Xie。
